X
skip to main content
Logo

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS

    Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cancer has relapsed or for whom current treatments are ineffective or non-existent.

    Read More View all notices

  • “Smart” nanoparticle called PEARLs a promising gem to target, treat tumours with greater precision

    Dr. Gang Zheng and a team of biomedical researchers have discovered a “smart” organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.

    Read More View all notices

  • Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood

    International stem cell scientists, co-led in Canada by Terry Fox-funded scientist Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have discovered the switch to harness the power of cord blood and potentially increase the supply of stem cells for cancer patients needing transplantation therapy to fight their disease.

    Read More View all notices

  • Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers

    Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer that has been notoriously difficult to accurately identify. The team has created an algorithm to diagnose and predict the clinical course of granulosa cell cancers of the ovary.

    Read More View all notices

Featured Patient Story

Bouncing back from radiation treatment to treat brain tumour

When Valeriya Zolotorgova was 10, her mother began to notice significant changes in the young girl’s hearing and vision. Following visits to doctors, Valeriya was eventually diagnosed with a brain tumour, medulloblastoma, the most common childhood malignant brain tumour with a 30 to 40 per cent mortality rate.

Read the full story
More patient stories

Watch our videos about TFRI-funded research on glioblastoma.

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.


Back to Top